Vitrosens Biotechnology headquartered in Turkey, by a group of entrepreneurs with a successful track record in building and scaling diagnostics and global health businesses. The company is a leading diagnostics firm committed to advancing science and improving the world through innovative technologies and groundbreaking research. Our company operates the largest rapid test kit facility in Turkey, and our manufacturing processes are carried out under EN ISO 9001: 2015 and ISO 13485: 2016 compliant quality systems. The company’s success is founded on our expertise in molecular biology, genetics, biochemistry, in-vitro-diagnostic (IVD), immunology, and point-of-care testing (POCT). Vitrosens Biotechnology has a wide product portfolio, providing a diverse range of diagnostic solutions. Our global reach spans over 50 countries. With an annual production capacity of 50 million tests, we continuously strive to enhance our manufacturing processes to exceed high-quality standards. Our company is present in our sub-brands, which include RapidFor, VetFor, DrugFor, ChainFor, Virasens, and Rapidsens in the global diagnostics market.